AlchiMedics is specialized in the coating of implantable medical devices for interventional cardiology and neurology, and structural heart. It has a specific expertise in building unprecedented coatings showing accelerated re-endothelialization and eliminating thrombosis, thus bringing patient safety to the next level by reducing the need for anti-platelet therapies. About 1.75 million patients, worldwide, are today implanted with devices powered by AlchiMedics’ technology, and growing.
Company Details
- Employees
- 5
- Founded
- 2007
- Address
- 28, Cours Albert 1er, Paris,île-De-France 75008,france
- Industry
- Medical Device
- Website
- https://alchimedics.com
- Keywords
- Coating, Polymers, Electrografting, Stents, Interventional cardiology, Drug release, Drug Eluting Stent, CD31, Neurological intervention, Coronary, Intracranial, Flow diverters, Anti-thrombotic coatings, re-endothelialization, Artery healing, Reduced anti-platelet therapy.
- HQ
- Paris, Île-de-France
Alchimedics Questions
Alchimedics's website is https://alchimedics.com
Alchimedics's LinkedIn profile is https://fr.linkedin.com/company/alchimedics-s-a-
Alchimedics has
5 employees.
View email and phone details for 5
employees at Alchimedics.
Alchimedics's industry is
Medical Device
Alchimedics's top competitors are
Neurosafe Medical Co., Ltd.,
Omini,
Npx Medical,
Rainmed Medical Inc.,
Praxy.ai,
Recross Cardio Inc.,
Sinomed,
Infineis,
Sinomed,
Tytek Medical Inc..
Alchimedics's categories are Medical Device
Alchimedics's founding year is 2007
